Open Orphan PLC - ESG Rating & Company Profile powered by AI
This report of Open Orphan PLC was assembled by All Street Sevva using cutting edge artificial intelligence. If you are employed by Open Orphan PLC and you wish to use your ESG rating, please contact us. The report of Open Orphan PLC uses data from across the internet as well as from available filings by Open Orphan PLC.
Open Orphan PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.7, social score of 1.6 and governance score of 4.0.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Open Orphan PLC | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Open Orphan PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Open Orphan PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Open Orphan PLC report the average age of the workforce?
Sign up for free to unlockDoes Open Orphan PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Open Orphan PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Open Orphan PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Open Orphan PLC offer flexible work?
Sign up for free to unlockDoes Open Orphan PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Open Orphan PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Open Orphan PLC conduct supply chain audits?
Sign up for free to unlockDoes Open Orphan PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Open Orphan PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Open Orphan PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Open Orphan PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Open Orphan PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Open Orphan PLC disclose water use targets?
Sign up for free to unlockDoes Open Orphan PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Open Orphan PLC have a product recall in the last two years?
Sign up for free to unlockDoes Open Orphan PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Open Orphan PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Open Orphan PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Open Orphan PLC disclose parental leave metrics?
Sign up for free to unlockDoes Open Orphan PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Open Orphan PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Open Orphan PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Open Orphan PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Open Orphan PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Open Orphan PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Open Orphan PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Open Orphan PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Open Orphan PLC disclose its waste policy?
Sign up for free to unlockDoes Open Orphan PLC report according to TCFD requirements?
Sign up for free to unlockDoes Open Orphan PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Open Orphan PLC disclose energy use targets?
Sign up for free to unlockDoes Open Orphan PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Open Orphan PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Open Orphan PLC
These potential risks are based on the size, segment and geographies of the company.
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom.